Literature DB >> 27082645

Association of pain intensity, pain-related disability, and depression with hypothalamus-pituitary-adrenal axis function in female patients with chronic temporomandibular disorders.

Kyung B Jo1, Young J Lee1, Il G Lee2, Sang C Lee3, Jai Y Park4, Ryun S Ahn5.   

Abstract

Patients with temporomandibular disorders (TMD) commonly experience myofascial and joint pain, pain-related disability, and other pain conditions including depression. The present study was carried out to explore the function of the hypothalamus-pituitary-adrenal (HPA) axis in relation to variables of the Research Diagnostic Criteria for Temporomandibular Disorders (RDC/TMD) Axis II and comorbid depression in female patients with TMD. Cortisol and dehydroepiandrosterone (DHEA) levels were determined in saliva samples that had been collected at various periods after waking (0, 30, and 60min) and at nighttime (2100-2200h) from 52 female patients with chronic TMD pain and age- and gender-matched controls (n=54, 20-40 years old). There were no significant differences in the levels and diurnal patterns of cortisol and DHEA secretion between groups of patients with TMD and controls. In patients, the cortisol awakening response (CAR) or diurnal cortisol rhythm were not associated with any variables of the RDC/TMD Axis II or the Beck Depression Inventory (BDI)-II total scores. However, the ratio of overall cortisol secretion within the first hour after waking (CARauc) to overall DHEA secretion during the post-waking period (Daucawk), defined as CARauc/Daucawk, was significantly associated with pain-related RDC/TMD variables (pain intensity and pain-related disability) and BDI-II total scores. Pain intensity and pain-related disability scores were also significantly associated with BDI-II total scores. These results indicated that an increase in molar cortisol/DHEA ratio due to the dissociation between cortisol and DHEA secretion was associated with pain intensity, pain-related disability, and depression in female patients with TMD.
Copyright © 2016. Published by Elsevier Ltd.

Entities:  

Keywords:  Depression; Pain intensity; Pain-related disability; TMD pain; cortisol/DHEA ratio

Mesh:

Substances:

Year:  2016        PMID: 27082645     DOI: 10.1016/j.psyneuen.2016.03.017

Source DB:  PubMed          Journal:  Psychoneuroendocrinology        ISSN: 0306-4530            Impact factor:   4.905


  6 in total

1.  Non-specific effects and clusters of women with painful TMD responders and non-responders to LLLT: double-blind randomized clinical trial.

Authors:  Laís Valencise Magri; Vinícius Almeida Carvalho; Flávia Cássia Cabral Rodrigues; César Bataglion; Christie Ramos Andrade Leite-Panissi
Journal:  Lasers Med Sci       Date:  2017-12-05       Impact factor: 3.161

2.  Potential Role of Obstructive Sleep Apnea on Pain Sensitization and Jaw Function in Temporomandibular Disorder Patients.

Authors:  Jeong-Hyun Kang; Hyun Jun Kim
Journal:  J Korean Med Sci       Date:  2022-10-10       Impact factor: 5.354

3.  Sciatic nerve injury rebalances the hypothalamic-pituitary-adrenal axis in rats with persistent changes to their social behaviours.

Authors:  M Karmina Sosa; Damien C Boorman; Kevin A Keay
Journal:  J Neuroendocrinol       Date:  2022-04-29       Impact factor: 3.870

Review 4.  The Role of Stress Regulation on Neural Plasticity in Pain Chronification.

Authors:  Xiaoyun Li; Li Hu
Journal:  Neural Plast       Date:  2016-12-08       Impact factor: 3.599

5.  Salivary Cortisol Levels and Burning Symptoms in Patients with Burning Mouth Syndrome before and after Low Level Laser Therapy: a Double Blind Controlled Randomized Clinical Trial.

Authors:  Ivana Škrinjar; Božana Lončar Brzak; Valentina Vidranski; Vanja Vučićević Boras; Ana Andabak Rogulj; Božidar Pavelić
Journal:  Acta Stomatol Croat       Date:  2020-03

6.  Functional, physical and psychosocial impact of Temporomandibular Disorders in adolescents and young adults.

Authors:  A-U Yap; L-Y Qiu; V-P Natu; M-C Wong
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2020-03-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.